Medicare Mulls Coverage for Controversial Alzheimer’s Drug

Published on July 13, 2021

Medicare launched a formal process on Monday that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer’s drug whose high price tag and unproven benefits have prompted widespread controversy. Medicare’s announcement came the same day that leaders…

Read Full Article (External Site)